University of Michigan Medical School at AMP 2026
Nov 10–14, 2026 Seattle, WA ~2k attendees Website
University of Michigan Medical School brings 2 presentations to AMP 2026 in Seattle. Its programme centres on comprehensive genomic profiling in precision oncology and on detecting rearrangements in blood cancers. The haematology side uses proximity ligation sequencing, also called Hi-C, to find oncogene rearrangements in lymphoid cancers, while the profiling session pairs tissue and liquid biopsy.
| Organization | AMP 2026 Attendance |
|---|---|
University of Michigan Medical School Ann Arbor, MI | |
Medical school in Ann Arbor, part of Michigan Medicine, with clinical molecular pathology and cancer sequencing programmes. | Workshop Wed, Nov 11 11:00am–11:50am Expanding Precision Oncology: Practical Strategies for Integrating Tissue and Liquid Biopsy Comprehensive Genomic Profiling Tissue and liquid biopsy genomic profiling run side by side, covering test algorithms, lab operations and case examples. Talk Sat, Nov 14 11:15am–11:45am Proximity Ligation Sequencing (Hi-C) for Oncogene Rearrangements in Lymphoid Cancers Proximity ligation sequencing on FFPE lymphoid cancer biopsies to catch enhancer-hijacking rearrangements that RNA-based methods miss. |
Instantly find 20 buyers from University of Michigan Medical School
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction